Stock 600613 SHANGHAI SHENQI PHARMACEUTICAL INVESTMENT MANAGEMENT CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.

Equities

600613

CNE000000453

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 03:30:00 26/06/2024 am IST 		5-day change 1st Jan Change
5.49 CNY +4.37% Intraday chart for Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. -1.61% -27.86%
29/04 Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
29/04 Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Shanghai Shenqi Pharmaceutical Investment Management Co.,Ltd. is a China-based company principally engaged in research and development, manufacture and sale of pharmaceuticals. The Company’s products are targeted for the treatment of influenza, cardio cerebrovascular diseases, rheumatoid bone diseases and in the areas of oncology, antifungal, antipyretic and gynaecology. The Company's main products include cantharidin sodium vitamin B6 injection, cantharidin sodium injection and other Chinese patent drug products. The Company distributes its products in domestic market.

Number of employees: 1,426

Sales per Business

CNY in Million2022Weight2023Weight Delta
Other
41.8 %
965 40.4 % 978 41.8 % +1.35%
Anti-tumor Drug
30.1 %
848 35.5 % 704 30.1 % -16.98%
Traditional Chinese Medicine Cough Relief
12.5 %
219 9.2 % 292 12.5 % +33.77%
Three High Chronic Disease Product
4.6 %
93 3.9 % 107 4.6 % +14.14%
Skin External Antibacterial
3.8 %
101 4.2 % 90 3.8 % -10.82%
Miao Medicine Muscle and Bone Strengthening
3.8 %
82 3.4 % 89 3.8 % +8.33%
Classic Tonic Product
2.2 %
46 1.9 % 50 2.2 % +10.11%
Magic Baby Medicine
1.3 %
35 1.5 % 31 1.3 % -12.32%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
2,389 100.0 % 2,341 100.0 % -2.00%

Managers

Managers TitleAgeSince
Bin Feng CEO
 Chief Executive Officer 52 01/05/01
Ke Jing Wu SEC
 Corporate Secretary 47 28/17/28

Members of the board

Members of the board TitleAgeSince
Shi Gui Chen BRD
 Director/Board Member 61 29/20/29
Bin Feng CEO
 Chief Executive Officer 52 01/05/01
Zhi Ting Zhang BRD
 Director/Board Member 80 26/20/26
Tao Tao Zhang CHM
 Chairman 44 26/14/26
Tao Wu BRD
 Director/Board Member 52 16/13/16
Dan Xu BRD
 Director/Board Member 53 26/14/26
Lan Hu BRD
 Director/Board Member 55 22/07/22
Cong Yan Li BRD
 Director/Board Member 58 29/20/29
Ke Jing Wu SEC
 Corporate Secretary 47 28/17/28
Zhi Mian Chen DFI
 Director of Finance/CFO 53 29/22/29

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 54,751,650 54,751,650 ( 100.00 %) 0 49.01 %
Stock B 1 479,319,978 207,010,338 ( 43.19 %) 0

Shareholders

NameEquities%Valuation
Shanghai Guotai Junan Securities Assets Management Co., Ltd.
0.1072 %
513,600 0.1072 % 438 871 ¥
China Southern Asset Management Co., Ltd.
0.0235 %
112,700 0.0235 % 96 302 ¥
Broad Fund Management Co. Ltd.
0.009993 %
47,900 0.009993 % 40 931 ¥
Fullgoal Fund Management Co., Ltd.
0.005299 %
25,400 0.005299 % 21 704 ¥
Guotai Asset Management Co., Ltd.
0.000250 %
1,200 0.000250 % 1 025 ¥

Company contact information

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.

Room 613, Changfa Building 128, Weihai Road

200003, Shanghai

+

http://www.gzsq.com
address Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.(600613)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sector Other Pharmaceuticals

1st Jan change Capi.
SHANGHAI SHENQI PHARMACEUTICAL INVESTMENT MANAGEMENT CO., LTD. Stock Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.
-27.86% 369M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+54.99% 815B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+44.25% 654B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.41% 354B
MERCK & CO., INC. Stock Merck & Co., Inc.
+21.87% 337B
ABBVIE INC. Stock AbbVie Inc.
+10.79% 302B
ASTRAZENECA PLC Stock AstraZeneca PLC
+18.45% 247B
ROCHE HOLDING AG Stock Roche Holding AG
+2.09% 229B
NOVARTIS AG Stock Novartis AG
+13.03% 219B
AMGEN INC. Stock Amgen Inc.
+8.77% 171B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 600613 Stock
  4. Company Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.